Vitruvias Thyroid Tablets Recall Alert | Amarillo News

Vitruvias Therapeutics is recalling a specific batch of their 30mg thyroid tablets after testing revealed they may be “superpotent,” risking hyperthyroidism symptoms like weight loss, heat sensitivity, fatigue, or heart issues—especially for older adults, pregnant women, and babies. Affected pills were distributed between Jan 31, 2025, and Sept 30, 2025, with lot number 504950. Don’t stop taking them abruptly—consult your doctor or Vitruvias for next steps. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/bc6f7d7622a959dc